KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Net Margin: 2015-2025

Historic Net Margin for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 8.84%.

  • BeOne Medicines' Net Margin rose 2096.00% to 8.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year increase of 2732.00%. This contributed to the annual value of -16.92% for FY2024, which is 1894.00% up from last year.
  • BeOne Medicines' Net Margin amounted to 8.84% in Q3 2025, which was up 23.27% from 7.17% recorded in Q2 2025.
  • BeOne Medicines' Net Margin's 5-year high stood at 27.57% during Q3 2023, with a 5-year trough of -320.24% in Q2 2021.
  • In the last 3 years, BeOne Medicines' Net Margin had a median value of -12.96% in 2024 and averaged -20.73%.
  • In the last 5 years, BeOne Medicines' Net Margin skyrocketed by 74,050bps in 2021 and then crashed by 15,291bps in 2022.
  • Quarterly analysis of 5 years shows BeOne Medicines' Net Margin stood at -276.04% in 2021, then soared by 15,888bps to -117.16% in 2022, then spiked by 5,923bps to -57.94% in 2023, then spiked by 4,447bps to -13.47% in 2024, then spiked by 2,096bps to 8.84% in 2025.
  • Its last three reported values are 8.84% in Q3 2025, 7.17% for Q2 2025, and 0.11% during Q1 2025.